US_chip

Washington eyes stake in Intel – and a bigger hand in America’s chip future

Jacob Falkencrone 400x400
Jacob Falkencrone

Global Head of Investment Strategy

Key points:

  • Washington is considering an equity stake in Intel, signalling a shift from subsidising to owning strategic tech assets.
  • The move could inject capital and political backing into Intel’s delayed Ohio fab project, but also bring constraints.
  • For investors, the structure and terms of any deal will be as important as the headline.

The White House is weighing a move that could redefine America’s approach to industrial policy – taking an equity stake in Intel. If realised, it would be the boldest step yet from subsidising domestic chip production to actually owning part of a company deemed critical to national security.

Markets reacted instantly. Intel’s shares surged more than 7% in Thursday’s regular session and climbed another 4% after hours. That kind of jump reflects more than just optimism over short-term cash flow – it’s a sign investors understand the far-reaching implications of Washington becoming a shareholder in a USD 100 billion technology giant.

It would be a rare move in peacetime. The last comparable interventions were during the 2008–09 financial crisis, when the US government took stakes in General Motors and AIG. Then, the motive was survival. Now, it’s about resilience – building and safeguarding America’s capacity to produce the advanced semiconductors that power everything from smartphones to missile systems.

“This isn’t just about one company’s turnaround – it’s about the US putting skin in the game in a strategic tech war.”

How the Intel–Washington talks unfolded

  • Early August: President Trump publicly called for Intel CEO Lip-Bu Tan to resign over past business links to China.
  • Monday: Tan met with Trump at the White House, in what both sides described as a “constructive” meeting.
  • Thursday: Bloomberg reported the administration is considering buying a stake in Intel, potentially to accelerate the long-delayed Ohio manufacturing hub – once billed as the world’s largest chipmaking facility.

The discussions are still exploratory. No agreement has been reached on the size, price or structure of the stake, and both the White House and Intel emphasise the talks remain speculative.

Why this deal would mark a turning point for US industrial policy

This would mark a decisive evolution in the US government’s role in the semiconductor industry. Intel is already set to receive USD 8.5 billion in grants and access to USD 11 billion in loans under the CHIPS and Science Act. Moving from financial support to equity ownership would put Washington inside the room when strategic decisions are made.

The national security logic is clear. Taiwan produces most of the world’s leading-edge chips, making the US dependent on an island at the centre of geopolitical tensions. Intel is America’s only integrated chipmaker capable of manufacturing such chips domestically – but it is behind schedule and financially stretched.

For policymakers, an equity stake could help secure domestic capacity and ensure the Ohio fab gets built on a faster timeline. For investors, the calculus is more complex. A government buy-in might strengthen Intel’s balance sheet and bring stability to its turnaround. But it could also mean strategic decisions shaped by political priorities, not purely by shareholder value.

“When politics and production schedules collide, the outcome is never certain – but the stakes for Intel’s future just went up.”

Three possible deal structures – and why they matter for investors

  • Convertible preferred shares or warrants: Capital without immediate dilution, though potential overhang if converted.
  • Straight equity: Simple but likely tied to conditions on buybacks, dividends and manufacturing priorities.
  • ‘Golden share’: Minimal equity but maximum influence, with veto power over strategic moves.

The form matters. A clean, investor-friendly structure with limited strings could be a confidence boost. A deal loaded with political oversight could weigh on Intel’s agility – and its share price.

How a government stake could reshape Intel – and the chip industry

For Intel, the backing could provide the financial and political capital to keep its manufacturing ambitions alive. It could also give potential foundry customers more confidence in the company’s ability to deliver – particularly those prioritising secure, US-based production. But government involvement will almost certainly bring constraints on capital allocation, export compliance and where chips are made.

Competitors would also feel the ripple. Nvidia, AMD and Qualcomm could face subtle pressure to use Intel’s US fabs, supporting its foundry unit but potentially distorting competition. Abroad, rivals like TSMC and Samsung may push for increased state backing from their own governments, intensifying the global subsidy race in chips.

From a policy perspective, an equity stake would formalise a pattern of direct government involvement in strategic industries – from the “golden share” in US Steel to revenue-sharing agreements on semiconductor sales to China. This could easily expand beyond semiconductors if other sectors are judged too vital to leave solely to market forces.

Wall Street’s split view: lifeline or political overreach?

The immediate rally reflects hopes that a government partnership could rescue the Ohio project and cement Intel’s place in US chip strategy. But it also builds in expectations for a deal that may never happen, or that could emerge in a form less favourable than markets currently assume.

Some investors view this as a potential inflection point in Intel’s comeback. Others see nationalisation risk – a scenario where political goals outweigh commercial priorities. Either way, capital alone will not restore Intel’s technology leadership; it will still need to close the gap with TSMC in manufacturing and with Nvidia in AI.

The signals that could move Intel’s share price next

All eyes will be on official signals from the White House, Commerce Department and Pentagon. Any detail on stake size, governance rights or customer commitments for the Ohio fab will move the stock. Progress – or further delays – in Ohio construction will be another key indicator, as will news of major foundry client wins.

“Investors often talk about tailwinds. Here, the wind is coming straight from the West Wing – and it can just as easily change direction.”

Bottom line for investors – where opportunity meets political risk

For now, this is a political story with market consequences. Traders should be ready for volatility as headlines break. Longer-term investors need to focus less on whether Washington writes the cheque, and more on whether Intel can turn additional capital into technology parity and reliable foundry business.

The broader point is this: if Washington is willing to take a stake in Intel, it may be prepared to do the same in other “strategic” companies. That’s a shift worth considering across the portfolio – not just in semiconductors, but in any sector that could be deemed critical to national security in the years ahead.

 

 





This material is marketing content and should not be regarded as investment advice. Trading financial instruments carries risks and historic performance is not a guarantee of future results.

The instrument(s) referenced in this content may be issued by a partner, from whom Saxo receives promotional fees, payment or retrocessions. While Saxo may receive compensation from these partnerships, all content is created with the aim of providing clients with valuable information and options.

 

 

Outrageous Predictions 2026

01 /

  • Executive Summary: Outrageous Predictions 2026

    Outrageous Predictions

    Executive Summary: Outrageous Predictions 2026

    Saxo Group

    Read Saxo's Outrageous Predictions for 2026, our latest batch of low probability, but high impact ev...
  • A Fortune 500 company names an AI model as CEO

    Outrageous Predictions

    A Fortune 500 company names an AI model as CEO

    Charu Chanana

    Chief Investment Strategist

    Can AI be trusted to take over in the boardroom? With the right algorithms and balanced human oversi...
  • Dollar dominance challenged by Beijing’s golden yuan

    Outrageous Predictions

    Dollar dominance challenged by Beijing’s golden yuan

    Charu Chanana

    Chief Investment Strategist

    Beijing does an end-run around the US dollar, setting up a framework for settling trade in a neutral...
  • Dumb AI triggers trillion-dollar clean-up

    Outrageous Predictions

    Dumb AI triggers trillion-dollar clean-up

    Jacob Falkencrone

    Global Head of Investment Strategy

    Agentic AI systems are deployed across all sectors, and after a solid start, mistakes trigger a tril...
  • Quantum leap Q-Day arrives early, crashing crypto and destabilizing world finance

    Outrageous Predictions

    Quantum leap Q-Day arrives early, crashing crypto and destabilizing world finance

    Neil Wilson

    Investor Content Strategist

    A quantum computer cracks today’s digital security, bringing enough chaos with it that Bitcoin crash...
  • SpaceX announces an IPO, supercharging extraterrestrial markets

    Outrageous Predictions

    SpaceX announces an IPO, supercharging extraterrestrial markets

    John J. Hardy

    Global Head of Macro Strategy

    Financial markets go into orbit, to the moon and beyond as SpaceX expands rocket launches by orders-...
  • Taylor Swift-Kelce wedding spikes global growth

    Outrageous Predictions

    Taylor Swift-Kelce wedding spikes global growth

    John J. Hardy

    Global Head of Macro Strategy

    Next year’s most anticipated wedding inspires Gen Z to drop the doomscrolling and dial up the real w...
  • Britain’s Great EU Backdoor Return

    Outrageous Predictions

    Britain’s Great EU Backdoor Return

    Neil Wilson

    Investor Content Strategist

    Faced with rolling fiscal, economic, trade and political crises the UK government sneaks back into t...
  • Obesity drugs for everyone – even for pets

    Outrageous Predictions

    Obesity drugs for everyone – even for pets

    Jacob Falkencrone

    Global Head of Investment Strategy

    The availability of GLP-1 drugs in pill form makes them ubiquitous, shrinking waistlines, even for p...
  • Despite concerns, U.S. 2026 mid-term elections proceed smoothly

    Outrageous Predictions

    Despite concerns, U.S. 2026 mid-term elections proceed smoothly

    John J. Hardy

    Global Head of Macro Strategy

    In spite of outstanding threats to the American democratic process, the US midterms come and go cord...

This content is marketing material. 

None of the information provided on this website constitutes an offer, solicitation, or endorsement to buy or sell any financial instrument, nor is it financial, investment, or trading advice. Saxo Capital Market Ltd. (SCML) provides execution-only services, with all trades and investments based on self-directed decisions. Analysis, research, and educational content is for informational purposes only and should not be considered advice or a recommendation.

SCML content may reflect the personal views of the author, which are subject to change without notice. Mentions of specific financial products are for illustrative purposes only and may serve to clarify financial literacy topics. Content classified as investment research is marketing material and does not meet legal requirements for independent research.

SCML partners with companies that provide compensation for promotional activities conducted on its platform. Some partners also pay retrocessions contingent on clients investing in products from those partners. 

While SCML receives compensation from these partnerships, all educational and research content remains focused on providing information to clients.

Before making any investment decisions, you should assess your own financial situation, needs, and objectives, and consider seeking independent professional advice. SCML does not guarantee the accuracy or completeness of any information provided and assumes no liability for any errors, omissions, losses, or damages resulting from the use of this information.

Please refer to our full disclaimer and notification on non-independent investment research for more details.

Saxo
40 Bank Street, 26th floor
E14 5DA
London
United Kingdom

Contact Saxo

United Kingdom
United Kingdom

Trade Responsibly
All trading carries risk. To help you understand the risks involved we have put together a series of Key Information Documents (KIDs) highlighting the risks and rewards related to each product. Read more
Additional Key Information Documents are available in our trading platform.

Saxo is a registered Trading Name of Saxo Capital Markets UK Ltd (‘Saxo’). Saxo is authorised and regulated by the Financial Conduct Authority, Firm Reference Number 551422. Registered address: 26th Floor, 40 Bank Street, Canary Wharf, London E14 5DA. Company number 7413871. Registered in England & Wales.

This website, including the information and materials contained in it, are not directed at, or intended for distribution to or use by, any person or entity who is a citizen or resident of or located in the United States, Belgium or any other jurisdiction where such distribution, publication, availability or use would be contrary to applicable law or regulation.

It is important that you understand that with investments, your capital is at risk. Past performance is not a guide to future performance. It is your responsibility to ensure that you make an informed decision about whether or not to invest with us. If you are still unsure if investing is right for you, please seek independent advice. Saxo assumes no liability for any loss sustained from trading in accordance with a recommendation.

Apple, iPad and iPhone are trademarks of Apple Inc., registered in the U.S. and other countries. App Store is a service mark of Apple Inc. Android is a trademark of Google Inc.

©   since 1992